Amylyx Pharmaceuticalsstock headed for its best day ever after the company said its investigational GLP-1 receptor antagonist, avexitide, met both the primary and secondary endpoints in a late-stage … [+114 chars]
No comments yet. Be the first to comment!
Your trusted source for breaking news, in-depth analysis, and comprehensive coverage of today's most important stories.
Get daily updates on breaking news, exclusive interviews, and special features delivered to your inbox.
Have a news tip or want to get in touch with our editorial team? We're here to help.
Plot C3-C Jaypee Wishtown Sector 129 Noida Uttar Pradesh 201304 India